Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule (original) (raw)

Discovery and optimization of nonpeptide HIV-1 protease inhibitors

Bioorganic & Medicinal Chemistry, 1996

Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2 D NMR, and Molecular Simulation Studies

Bahareh Honarparvar, Yasien Sayed

ChemMedChem, 2012

View PDFchevron_right

Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors

Roger Tung

Bioorganic & Medicinal Chemistry Letters, 1998

View PDFchevron_right

INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design 1

Alexander Wlodawer

Annual Review of Biophysics and Biomolecular Structure, 1998

View PDFchevron_right

An In silico Approach for Identification of Novel Inhibitors as a Potential Therapeutics Targeting HIV-1 Viral Infectivity Factor

Anuraj Nayarisseri

Current Topics in Medicinal Chemistry. Vol 15, Issue Num 1, pp 65 - 72, 2015

View PDFchevron_right

Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance

Md Akbar Ali

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Future appeal of comparative studies on putative binding sites of HIV-1 virus-encoded proteolytic enzyme inhibitor of different Food and Drug Administration-approved compounds

SAMI MELEBARI

HIV & AIDS Review

View PDFchevron_right

Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design

D. Decamp, Elaine Meng

The Journal of biological chemistry, 1993

View PDFchevron_right

Novel Protease Inhibitors (PIs) Containing Macrocyclic Components and 3(R),3a(S),6a(R)-bis-Tetrahydrofuranylurethane That Are Potent against Multi-PI-Resistant HIV-1 Variants In Vitro

Masayuki Amano

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection

Peng Zhan

Viruses

View PDFchevron_right

New Active HIV-1 Protease Inhibitors Derived from 3-Hexanol: Conformation Study of the Free Inhibitors in Crystalline State and in Complex with the Enzyme

Jindřich Hašek

Chemical Biology & Drug Design, 2012

View PDFchevron_right

Design, Synthesis, Evaluation, and Crystallographic-Based Structural Studies of HIV1 Protease Inhibitors with Reduced Response to the V82A Mutation

F. Javier Sardina

Journal of Medicinal Chemistry, 2008

View PDFchevron_right

Conformationally constrained HIV-1 protease inhibitors

Joseph Vacca

Bioorganic & Medicinal Chemistry Letters, 1994

View PDFchevron_right

Design, Synthesis and Screening of Novel PCU-peptide/peptoid Derived HIV Protease Inhibitors

Maya Makatini

View PDFchevron_right

Synthesis and anti-HIV activities of urea-pETT analogs belonging to a new class of potent non-nucleoside HIV-1 Reverse transcriptase inhibitors

Per Engelhardt

Bioorganic & Medicinal Chemistry Letters, 1998

View PDFchevron_right

Inhibitors of HIV Protease: Unique Non‐peptide Active Site Templates

Christopher Gajda

Journal of Molecular Recognition, 1996

View PDFchevron_right

Potent New Antiviral Compound Shows Similar Inhibition and Structural Interactions with Drug Resistant Mutants and Wild Type HIV-1 Protease †

Yuan-fang Wang, Irene Weber

Journal of Medicinal Chemistry, 2007

View PDFchevron_right

Potency Comparison of Peptidomimetic Inhibitors against HIV-1 and HIV-2 Proteinases: Design of Equipotent Lead Compounds

Juraj Sedláček

Archives of Biochemistry and Biophysics, 1997

View PDFchevron_right

Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV-1 protease inhibitors. A 3D-QSAR-CoMFA method for new antiviral drug design

Igor Švab

Journal of Cellular and Molecular Medicine, 2003

View PDFchevron_right

Novel HIV-1 Protease Inhibitors (PIs) Containing a Bicyclic P2 Functional Moiety, Tetrahydropyrano-Tetrahydrofuran, That Are Potent against Multi-PI-Resistant HIV-1 Variants

Masayuki Amano

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Novel inhibitors of HIV protease

Roger Tung

Bioorganic & Medicinal Chemistry Letters, 2000

View PDFchevron_right

Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

Hiroyuki Gatanaga

J. Med. …, 2006

View PDFchevron_right

An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV‐1 protease variants

Ishwar Chandra D

Journal of Cellular Biochemistry, 2018

View PDFchevron_right

Molecular docking and 3D-QSAR studies of HIV1 protease inhibitors

Raghuvir Pissurlenkar

Journal of Molecular Modeling, 2010

View PDFchevron_right

Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease

Per Arvidsson

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

Structure–activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids. Detailed study of P1 site

Shuichi Miyamoto

Bioorganic & Medicinal Chemistry, 1999

View PDFchevron_right

Structure Based Design of Inhibitors of Aspartic Protease of HIV-1

Alessandro Tossi

Letters in Drug Design & Discovery, 2005

View PDFchevron_right

Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule (original) (raw)

Related papers